Breaking News, Promotions & Moves

Lannett Appoints New CEO

Timothy C. Crew brings nearly three decades of pharmaceutical experience to the company

Lannett Company announced that its board of directors has named Timothy C. Crew as the company’s chief executive officer, effective January 2, 2018.  The Board of Directors intends to appoint Crew as a director of the company after completion of its 2018 Annual Meeting of Stockholders.    Crew has more than 25 years of experience in the generic and branded pharmaceutical industries, most recently serving as CEO of Cipla North America, a global pharmaceutical company based in Mumbai...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters